CClinicalTrials.gg
RecruitingNCT06423222Updated May 21, 2024

Anal Incontinence and Its Impact on Quality of Life and Physical Activity Among Hungarian Women and the Hungarian Language Validation of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)

An observational study in Anal Incontinence, sponsored by University of Pecs. Recruiting at 1 site in Hungary. Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-21.

Sponsored by University of Pecs · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Apr 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
250
Ages
18 Years to 50 Years
Sex
Female
01

Study summary

The aim of the study is to assess the prevalence of anal incontinence among Hungarian women who have given birth at least once before, and to examine the impact of anal incontinence on the quality of life and physical activity of these women. A further aim of our study is to adapt the Hungarian version of the International Consultation on Incontinence Modular Questionnaire - Bowels (ICIQ-B) and to assess its validity and reliability.

02

Conditions studied

  • Anal Incontinence

Browse trials for

Keywords

  • Anal Incontinence
  • Quality of Life
  • Physical Activity
  • Questionnaire
03

In context

Fecal Incontinence

312 studies on the registry are indexed under Fecal Incontinence; 57 are open to participants now.

This study's planned enrollment of 250 is above the median of 100 across 79 observational studies indexed under Fecal Incontinence.

Browse Fecal Incontinence studies →

Lead sponsor

University of Pecs is the lead sponsor of 100 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

We plan to include subjects who are female, over the age of 18, under the age of 50 and who have given birth at least once before.

Inclusion criteria

  • Have given birth at least once before
  • Native Hungarian language

Exclusion criteria

Exclusion Criteria:

  • Menopause
  • Irritable Bowel Syndrome (IBS)
  • Chron's disease
  • Ulcerative colitis
  • Developmental abnormalities at the level of the pelvic organs
  • Uninvestigated pelvic pain
  • Malignant pelvic tumor
  • Radiotherapy involving the pelvis
  • Neurological diseases with muscle weakness
  • Parkinson's disease
  • Intellectual disability
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
250 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Anal Incontinence Impact on Quality of Life

    Assessing with questionnaire: International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B). The ICIQ-B is a patient-completed questionnaire to assess the symptoms and impact on quality of life (QoL) of anal incontinence (including flatus incontinence). The ICIQ-B consists of 21 items, divided into three domains: Bowel pattern (1 - 21), bowel control (0 - 28), Quality of life (0 - 26). Seventeen items are scored items and the remaining four are unscored. Higher scores indicate more symptoms.

    Time frame: Through study completion, an average of 3 years

  2. Anal Incontinence Impact on Physical Activity

    Assessing with questionnaire: Global Physical Activity Questionnaire (GPAQ). The Global Physical Activity Questionnaire was developed by WHO to monitor physical activity in countries. It collects information from 16 questions (P1-P16) on participation in physical activity in three domains (Workplace activity, Travel to and from places, Leisure activities) and sedentary behavior. Metabolic equivalent (MET) values are applied to the time variables according to the intensity of the activity (moderate or high). The application of MET values to activity levels allows the calculation of total physical activity.

    Time frame: Through study completion, an average of 3 years

  3. Adaptation, validity and reliability of the Hungarian version of the International Consultation on Incontinence Modular Questionnaire-Bowels (ICIQ-B)

    Evaluating with statistical analysis the content/face validity, internal consistency, construct validity, test-retest reproducibility, discriminant validity and convergent validity.

    Time frame: Through study completion, an average of 3 years

Secondary outcomes

  1. Additional pelvic floor symptoms

    Assessing with questionnaire: The Hungarian version of the Australian Pelvic Floor Questionnaire (APFQ-H). The APFQ-H consists of four domains: bladder function (15 items), bowel function (12 items), prolapse symptoms (5 items) and sexual function (10 items). Thirty-eight of the items assess pelvic floor symptoms and four questions assess the bother caused by symptoms in each domain. Most items in the questionnaire use a 4-point scoring system. The score obtained for each domain ranges from 0 to 10. The sum of the subscores in the four domains gives the APFQ-H global score. The higher the score, the more severe the pelvic floor symptoms.

    Time frame: Through study completion, an average of 3 years

  2. Global Quality of Life

    Assessing with questionnaire: Hungarian WHOQOL-BREF. The WHOQOL-BREF is a self-administered questionnaire that contains 26 questions about an individual's health and well-being over the previous two weeks. Answers to the questions are given on a Likert scale of 1-5. The WHOQOL-BREF covers four domains (physical health, psychological, social relationships, environment). Scores in each of the 4 domains are converted into a scale ranging from 0 to 100. A score of 0 represents the worst possible health status, while a score of 100 represents the best possible health status for that domain.

    Time frame: Through study completion, an average of 3 years

07

Study locations

1 of 1 sites recruiting
  • Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs
    Pécs, Baranya H-7621, Hungary
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06423222
Lead sponsor
University of Pecs
Responsible party
Sponsor
First posted
May 21, 2024
Start date
Apr 22, 2024
Primary completion
Jan 2026 (estimated)
Completion
Jul 2027 (estimated)
Last update
May 21, 2024

Study contacts

Márta Hock, PhD
Contact
hock.marta@etk.pte.hu
+36-30-7213156
Eszter Ambrus
Contact
eszterkaja@gmail.com
Márta Hock, PhD
study director · University of Pécs Faculty of Health Sciences
Eszter Ambrus
principal investigator · Doctoral School of Health Sciences, Faculty of Health Sciences, University of Pécs, Pécs, Hungary

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion